A randomized, double-blind, placebo-controlled, multi-center phase III clinical trial to evaluate the efficacy and safety of Bupleurum nasal spray in treating caused by the common cold (acute upper respiratory tract infection).

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 5316ca0188cd9ecad42c354ff5aa44fa6d1ffd8b
First added on: May 10, 2025